The landscape of modern psychopharmacology is experiencing a fundamental transformation as academic institutions and clinical laboratories evaluate the therapeutic potential of entheogenic compounds. Across an interconnected global network encompassing the United States, the United Kingdom, Germany, Japan, China, Canada, France, the Netherlands, Switzerland, Australia, Dubai, Finland, and Austria, researchers are systematically replacing mid-century stigma with […]